ALA arovella therapeutics limited
Add to My Watchlist 18.8% ! 9.5¢

Claudin 18.2 target for gastric (solid) cancers

  1. Bluebush
    2,344 Posts.
    lightbulb Created with Sketch. 347
    clock Created with Sketch.
    13/06/24
    08:15
    Post #: 74289465
    Still waiting on in-vitro proof of concept trial in H1 and then the very important in-vivo trials in H2.

    In terms of proof of concept results there seems no doubt that the CLDN 18.2 protein is a good target for gastric cancers (Claudin 18.2 as a novel therapeutic target | Nature Reviews Clinical Oncology) so the question is how effective is this iNKT CAR.

    Given the ALA share price re-rate in March last year was in response to in-vivo results from ALA101. A significant result (from CLDN18.2 targeted in vivo trials, in a solid cancer should re-rate again and make ALA a solid 2 product company.

    upload_2024-6-13_5-52-46.png
    ALA Price at posting: 14.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.5¢ 		Change
0.015(18.8%) 		Mkt cap ! $113.6M
Open High Low Value Volume
8.1¢ 9.5¢ 8.1¢ $182.2K 2.104M

Buyers (Bids)

No. Vol. Price($)
1 141934 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.